• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Antengene Showcases Next-Gen ADCs, AnTenGager TCEs at AACR 2026

    FIRSTWORD PHARMA

    UCB enters TCE space with $1.1B Deal for Autoimmune Candidate

    PRESS RELEASE

    Antengene and UCB Enter Global License Agreement for ATG-201

    PR NEWSWIRE

    XPOVIO® Gains Reimbursement Approval in 2nd-Line Multiple Myeloma

    PR NEWSWIRE

    Antengene Highlights Clinical Data and ADC, TCE Strategy at JPM

    PR NEWSWIRE

    Malaysia Approves Antengene`s XPOVIO for DLBCL Treatment

    PR NEWSWIRE

    Antengene Unveils ATG-201 Preclinical Data At ACR 2025

    PR NEWSWIRE

    Antengene Unveils ATG-022 Data At ESMO 2025 Showing Efficacy

    PR NEWSWIRE

    Antengene to Showcase ATG-201 Preclinical Results at ACR 2025

    PR NEWSWIRE

    Antengene`s 2025 Interim Results Show Promising Data

    PR NEWSWIRE

    Antengene`s ATG-022 Gets Breakthrough Therapy Status for Cancer

    PR NEWSWIRE

    Antengene to Present Clinical Results at ASCO 2025

    PR NEWSWIRE

    Antengene & MSD Enter into a Global Clinical Collaboration

    PR NEWSWIRE

    Antengene’s XPOVIO Gains Public Health Insurance Coverage In Taiwan

    PR NEWSWIRE

    Antengene Initiates Ph II Dose Study of ATG-022 in China and Australia

    PR NEWSWIRE

    Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101

    PR NEWSWIRE

    Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031

    PR NEWSWIRE

    Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

    PR NEWSWIRE

    Antengene Announces First Patient Dosed in the Nivolumab Evaluating ATG-017

    PR NEWSWIRE

    Antengene Announces Clearance of U.S. IND for Monoclonal Antibody ATG-031

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.